Clinical trial
Naltrexone Treatment of Alcohol Abuse in Schizophrenia
NCT00145847 · State University of New York - Upstate Medical University, Other · Completed
Key facts
| NCT number | NCT00145847 |
|---|---|
| Title | Naltrexone Treatment of Alcohol Abuse in Schizophrenia |
| Official title | Naltrexone Treatment of Alcohol Abuse in Schizophrenia |
| Lead sponsor | State University of New York - Upstate Medical University, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Mental Disorders, Alcohol Abuse, Alcoholism, Alcohol-related Disorders |
| Intervention type | Drug |
| Interventions | Naltrexone or Placebo |
| Enrollment | 90 |
| Start date | Apr 1, 2003 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 5, 2005 |
| Last update posted | Jan 8, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: